tiprankstipranks
Advertisement
Advertisement

AU:ARX Stock Latest News

Aroa Biosurgery Director John Diddams Steps Down but Retains Indirect Stake
Company AnnouncementsAroa Biosurgery Director John Diddams Steps Down but Retains Indirect Stake
2d ago
ARX
Aroa Biosurgery shareholders back all resolutions at Annual General Meeting
PremiumCompany Announcements
Aroa Biosurgery shareholders back all resolutions at Annual General Meeting
4d ago
ARX
Aroa Biosurgery Issues Investor Education Presentation With Key Disclaimers
PremiumCompany Announcements
Aroa Biosurgery Issues Investor Education Presentation With Key Disclaimers
4d ago
ARX
Aroa Biosurgery Issues New Restricted Stock Units Under Employee Scheme
PremiumCompany Announcements
Aroa Biosurgery Issues New Restricted Stock Units Under Employee Scheme
11d ago
ARX
Aroa Biosurgery Issues 2.9 Million Restricted Stock Units Under Employee Incentive Plan
PremiumCompany Announcements
Aroa Biosurgery Issues 2.9 Million Restricted Stock Units Under Employee Incentive Plan
26d ago
ARX
Aroa Biosurgery strengthens US commercial leadership to drive global growth
PremiumCompany AnnouncementsAroa Biosurgery strengthens US commercial leadership to drive global growth
26d ago
ARX
Aroa Biosurgery Sets Fully Virtual 2026 AGM with Governance and CEO Incentive Votes
Premium
Company Announcements
Aroa Biosurgery Sets Fully Virtual 2026 AGM with Governance and CEO Incentive Votes
30d ago
ARX
Aroa Biosurgery Cuts Potential Dilution as Options and Rights Lapse
Premium
Company Announcements
Aroa Biosurgery Cuts Potential Dilution as Options and Rights Lapse
1M ago
ARX
Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates
PremiumCompany Announcements
Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates
1M ago
ARX
Aroa Biosurgery CFO James Agnew Resigns After 13 Years of Service
PremiumCompany Announcements
Aroa Biosurgery CFO James Agnew Resigns After 13 Years of Service
1M ago
ARX
Aroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance
PremiumCompany Announcements
Aroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance
2M ago
ARX
Aroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report
PremiumCompany Announcements
Aroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report
2M ago
ARX
Aroa Biosurgery director trims indirect shareholding in on-market sale
PremiumCompany AnnouncementsAroa Biosurgery director trims indirect shareholding in on-market sale
2M ago
ARX
Aroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement
Premium
Company Announcements
Aroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement
2M ago
ARX
Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
Premium
Company Announcements
Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
3M ago
ARX
Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
PremiumCompany Announcements
Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
3M ago
ARX
Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
PremiumCompany Announcements
Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
4M ago
ARX
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
PremiumCompany Announcements
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
4M ago
ARX
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
PremiumCompany Announcements
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
5M ago
ARX
Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
PremiumCompany AnnouncementsAroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
5M ago
ARX
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
Premium
Company Announcements
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
5M ago
ARX
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
Premium
Company Announcements
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
7M ago
ARX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >